Truist Financial initiated coverage on shares of Guardian Pharmacy Services (NYSE:GRDN – Free Report) in a report issued on Monday, Marketbeat.com reports. The firm issued a buy rating and a $22.00 price target on the stock.
Guardian Pharmacy Services Stock Performance
Shares of NYSE:GRDN opened at $17.08 on Monday. Guardian Pharmacy Services has a 12 month low of $14.16 and a 12 month high of $20.10.
Insider Activity at Guardian Pharmacy Services
In other news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were bought at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the acquisition, the director now owns 35,714 shares of the company’s stock, valued at approximately $499,996. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Institutional Investors Weigh In On Guardian Pharmacy Services
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
See Also
- Five stocks we like better than Guardian Pharmacy Services
- 3 Stocks to Consider Buying in October
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Stock Market Sectors: What Are They and How Many Are There?
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.